GCP
QTTB icon

GSA Capital Partners’s Q32 Bio QTTB Stock Holding History

GSA Capital Partners’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,601
Closed -$82K – 1993
2022
Q4 		$82K Sell
3,601
-2,339
-39% -$62.1K 0.01% 1325
2022
Q3 		$172K Sell
5,940
-1,191
-17% -$48.6K 0.02% 1274
2022
Q2 		$253K Sell
7,131
-5,556
-44% -$190K 0.04% 931
2022
Q1 		$694K Buy
12,687
+1,821
+17% +$113K 0.09% 348
2021
Q4 		$712K Buy
10,866
+3,394
+45% +$329K 0.09% 377
2021
Q3 		$1.06M Sell
7,472
-1,426
-16% -$182K 0.11% 287
2021
Q2 		$1.16M Buy
8,898
+6,742
+313% +$841K 0.13% 188
2021
Q1 		$365K Buy
2,156
+1,432
+198% +$302K 0.06% 527
2020
Q4 		$147K Sell
724
-1,059
-59% -$205K 0.02% 1052
2020
Q3 		$343K Buy
+1,783
New +$400K 0.06% 646

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

GSA Capital Partners's QTTB Position: Q1 2023 in Review

GSA Capital Partners sold out of Q32 Bio (QTTB) in Q1 2023, closing a stake of 3,601 shares — an estimated $82K sold.

GSA Capital Partners first reported a position in QTTB in Q3 2020 and held it in 10 quarters. The position peaked at $1.16M in Q2 2021. 62 funds tracked by Wall St. Rank hold QTTB as of Q1 2023.

  • GSA Capital Partners reported no remaining Q32 Bio position as of Q1 2023 after selling out during the quarter.
  • GSA Capital Partners sold 3,601 Q32 Bio shares in Q1 2023, an estimated $82K.
  • GSA Capital Partners first reported a position in Q32 Bio in Q3 2020 and held it in 10 quarters.
  • GSA Capital Partners's Q32 Bio position peaked at $1.16M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2023.

Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.